Page 340 - Vitamin D and Cancer
P. 340

Chapter 15
            Assessment of Vitamin D Status
            in the 21  Century
                        st


            Bruce W. Hollis







            Abstract  The field of Vitamin D assay technology has progressed significantly over
            the past 4 decades. Further, the clinical utility of these measurements has moved
            from esoteric into mainstream clinical diagnosis. This movement has been fueled
            by the realization that Vitamin D is involved in bodily systems beyond skeletal
            integrity. The clinical assay techniques for circulating 25(OH)D and 1,25(OH) D
                                                                            2
            have progressed away from competitive protein-binding assay (CPBAs) that utilize
            tritium reporters to radioimmunoassay (RIAs) that utilize both I125 and chemilu-
            minescent reporters. These advances have allowed direct serum analysis of 25(OH)
            D in an automated format that provides a huge sample throughput. Detection of
            circulating 25(OH)D can also be achieved utilizing direct high-performance liquid
            chromatographic (HPLC) or liquid chromatography coupled with mass spectrom-
            etry  (LC-MS)  techniques.  These  methods  are  accurate,  however,  they  require
            expensive equipment and restrict sample throughput in the large clinical labora-
            tory. Direct serum detection of 1,25(OH) D is unlikely to occur for many reasons
                                             2
            as a sample pre-purification will always be required. However, a semi-automated
            chemiluminescent detection system with automated sample preparation is in final
            development for the determination of circulating 1,25(OH) D. These advances will
                                                           2
            allow both 25(OH)D and 1,25(OH) D to be detected in an accurate, rapid fashion
                                        2
            to meet the clinical demands we see emerging.

            Keywords  Vitamin D assay • 25-hydroxyvitamin D • 1,25-dihydroxyvitamin D



            Disclosure  Dr. Hollis is an academic consultant to the DiaSorin Corp.





            B.W. Hollis (*)
            Department of Pediatrics,
            Darby Children’s Research Institute, Medical University of South Carolina,
            173 Ashley Ave., Room 313, Charleston, SC 29425, USA
            e-mail: holisb@musc.edu


            D.L. Trump and C.S. Johnson (eds.), Vitamin D and Cancer,       327
            DOI 10.1007/978-1-4419-7188-3_15, © Springer Science+Business Media, LLC 2011
   335   336   337   338   339   340   341   342   343   344   345